$ARIA Recent Headlines Six stocks to watch 3:27 p.m.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ARIA Recent Headlines

Six stocks to watch 3:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 3:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 9:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com


Will Ariad Pharmaceuticals (ARIA) Stock be Affected Today by This Analyst Action? 21 min ago - TheStreet.com
Analysts' Actions: AbbVie, Ariad, Lilly, Prologis, Toll Brothers 39 min ago - TheStreet.com
Top Analyst Upgrades and Downgrades: ARIAD, FedEx, Genpact, Suncor, Travelers, UPS and More 7:38 a.m. Today - 247WallSt.com
UPDATE: Credit Suisse Downgrades Ariad Pharmaceuticals As Launch Metrics Are Still Weak 7:06 a.m. Today - benzinga.com
Long-term follow up data for Iclusig positive 10:54 a.m. Dec. 9, 2014 - Seeking Alpha
ARIAD Reports Follow-up Data from Phase 1, PACE Trials of Ponatinib for T315I Mutation 6:37 a.m. Dec. 9, 2014 - benzinga.com
ARIAD Reports Long-term Safety, Efficacy Data of Ponatinib from Phase 2 Pace Trial: 83% of CP-CML Patients Achieved Response 6:36 a.m. Dec. 8, 2014 - benzinga.com
Trade-Ideas: ARIAD Pharmaceuticals (ARIA) Is Today's Post-Market Leader Stock 7:06 p.m. Dec. 3, 2014 - TheStreet.com
ARIAD Pharmaceuticals (ARIA) Is Strong On High Volume Today 10:00 a.m. Dec. 2, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – AVNR BIIB ARIA ACHN 6:15 a.m. Dec. 2, 2014 - InvestorPlace.com
Vargatef cleared in Europe for lung cancer 9:23 a.m. Nov. 28, 2014 - Seeking Alpha
Ariad Pharmaceuticals (ARIA) Jumps: Stock Gains 9.7% - Tale of the Tape 9:25 a.m. Nov. 25, 2014 - Zacks.com
Iclusig cleared in Australia 10:41 a.m. Nov. 24, 2014 - Seeking Alpha
ARIAD Pharmaceuticals (ARIA) Strong On High Relative Volume Today 10:04 a.m. Nov. 24, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ARIA PTCT PTCT CLDX 6:30 a.m. Nov. 24, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – ACAD CYH STJ PODD 6:30 a.m. Nov. 21, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – CLDX ARIA KND MDCO 6:45 a.m. Nov. 20, 2014 - InvestorPlace.com
'Mad Money' Lightning Round: A Group to Avoid 6:00 a.m. Nov. 14, 2014 - TheStreet.com
Cramer's Lightning Round - Affymetrix Teased And Disappointed, But Is A Buy (11/13/14) 3:40 a.m. Nov. 14, 2014 - Seeking Alpha
10-Q: ARIAD PHARMACEUTICALS INC 4:53 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)


ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial 7:35 a.m. Dec. 8, 2014 - BusinessWire - BZX
Insider Trading Alerts for Hertz, Ariad Pharmaceuticals, J C Penney, Sirius XM, Apple, and Sunedison 8:45 a.m. Nov. 25, 2014 - PR Newswire - PRF
ARIAD and STA Announce Approval of Iclusig (Ponatinib) in Australia 7:35 a.m. Nov. 24, 2014 - BusinessWire - BZX
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting 9:44 a.m. Nov. 6, 2014 - BusinessWire - BZX
ARIAD Reports Third Quarter 2014 Financial Results and Development Progress 7:36 a.m. Nov. 5, 2014 - BusinessWire - BZX
ARIAD to Present at the Stifel 2014 Healthcare Conference 7:35 a.m. Nov. 4, 2014 - BusinessWire - BZX
ARIAD Announces Adoption of Final Opinion for Iclusig by Committee for Medicinal Products for Human Use in Europe 6:35 a.m. Oct. 24, 2014 - BusinessWire - BZX
Insider Trading Alerts for Micron, CSX, Ariad Pharmaceuticals, IBM, SinoCoking Coal and Coke Chemical, and MannKind 7:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Insider Trading Research for Halliburton, Ariad Pharmaceuticals, KeyCorp, GoPro, MannKind, and Plug Power 7:45 a.m. Oct. 20, 2014 - PR Newswire - PRF
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 7:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on Third Quarter 2014 Financial Results 6:35 a.m. Oct. 15, 2014 - BusinessWire - BZX
ARIAD Announces Recommendation for Iclusig by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency 6:44 a.m. Oct. 10, 2014 - BusinessWire - BZX
ARIAD and Bellicum Announce Revised License Agreement for ARIAD’s Cell-Signaling Technology 6:35 a.m. Oct. 6, 2014 - BusinessWire - BZX
ARIAD’s AP26113 Receives FDA Breakthrough Therapy Designation For ALK+ Non-Small Cell Lung Cancer Resistant to Crizotinib 6:35 a.m. Oct. 2, 2014 - BusinessWire - BZX
ARIAD Presents Updated Clinical Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer 6:35 a.m. Sept. 29, 2014 - BusinessWire - BZX
INNATE PHARMA APPOINTS PIERRE DODION AS CHIEF MEDICAL OFFICER AND MEMBER OF THE EXECUTIVE COMMITTEE 11:41 a.m. Sept. 16, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 7:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 12:19 p.m. Aug. 19, 2014 - PR Newswire - PRF
ARIAD Reports Second Quarter 2014 Financial Results and Development Progress 10:34 p.m. Aug. 6, 2014 - BusinessWire - BZX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dickinson Brands Celebrates Witch Hazel Legacy with Event

Updated Category News Views 14

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Continue Reading
Art Print Paper: Finding the Perfect Match for Masterpieces

Updated Category News Views 8

You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...

Continue Reading
Florida Cancer Center Expands Expertise with New Oncologist

Updated Category News Views 8

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Continue Reading
Sarah Weede: A Force in Veterans Services Leadership

Updated Category News Views 5

Saluting a Veteran's Advocate Amidst a world obsessed with bottom lines and market swings, it’s refreshing to spotlight someone like Sarah R. Weede. She's not about the Wall Street grind but you better believe her drive and dedication rival any big-shot CEO. Leadership in Veterans Services Sarah Weede's story starts with substantial roots planted in serving those who...

Continue Reading
D2L Ventures into Vietnam with Van Lang Alliance

Updated Category News Views 6

Unlocking New Frontiers in Vietnam's Education Well, looks like D2L is rolling into Vietnam with the kind of gusto you'd expect from a company that fancies itself a trailblazer in learning tech. This ain't just another humdrum expansion story; it's a five-year handshake with Van Lang Education Group that's got the tech firm dropping its anchor in a fresh and promising...

Continue Reading
Navigating the Nitty-Gritty of Cabin Rental Management

Updated Category News Views 4

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Continue Reading
TomoIQ Unveils Money Finder at Money20/20 Event

Updated Category News Views 11

Breaking Down Financial Barriers with AI In the hustle of Money20/20 USA in Las Vegas, TomoIQ dropped a financial bombshell with their latest tool, Money Finder. This isn't just another app in the sea of fintech solutions. Nope, this one promises to cut through the complexities that most folks face when trying to get their financial house in order. An AI Buddy for...

Continue Reading
Firmable's Tech Intelligence: New Edge in B2B Sales

Updated Category News Views 5

New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...

Continue Reading
Taiwan Excellence Sparks Smart Automotive Innovation at SEMA

Updated Category News Views 1

Taiwan's making waves, folks, and it's not your everyday splash in the automotive pool. At SEMA 2026, Taiwan Excellence Pavilion is the place to be with its array of intelligent automotive solutions. This ain't just your run-of-the-mill car show gimmickry—it's the future rolling in real-time. Driving Innovation: From Components to Smart Systems The name of the game is...

Continue Reading
Ford Foundation Welcomes Gender Justice Leader Fatima Goss Graves

Updated Category News Views 5

A Fresh Addition to Ford's Trustees Fatima Goss Graves steps into big shoes at the Ford Foundation as she gets appointed to its Board of Trustees. No small potatoes, this move suggests the Foundation's commitment to driving significant gender justice and advocacy. Add her name next to serious change-makers, folks, because Ms. Goss Graves is a heavyweight in the nonprofit...

Continue Reading

Top 5 Most Recently Viewed Articles

AbbVie Inc: Key Trading Signals Boost Stock Performance

Updated Category News Views 155

Recent Trading Momentum for AbbVie Inc AbbVie Inc (NYSE: ABBV) has caught the attention of traders with significant fluctuations in stock prices, predominantly influenced by notable trading signals. Recently, the stock experienced an impressive Power Inflow alert, which traders regard as a critical bullish indicator. This alert hinges on valuable order flow analytics that...

Continue Reading
Ormat Technologies' 2024 Financial Performance Review

Updated Category News Views 352

Ormat Technologies' Strong Performance in 2024 Ormat Technologies, Inc. (NYSE: ORA), a prominent player in the renewable energy sector, has recently released its financial performance report for the fourth quarter and full year of 2024. This announcement marks another year of substantial growth, driven by a robust strategic approach that enhances its operational...

Continue Reading
Exploring State Street's Financial Metrics and Market Trends

Updated Category News Views 187

Current Stock Performance of State Street Currently, State Street Inc. (NYSE: STT) has a share price of $112.20, experiencing a minor decline of 0.21%. Despite this slight drop, it’s encouraging to note that the stock has seen an increase of 0.87% over the past month and a significant growth of 29.33% in the past year. This variability poses an intriguing question for...

Continue Reading
Fortrea Enhances Board with Financial Expert Erin L. Russell

Updated Category News Views 368

Fortrea Welcomes Erin L. Russell to Its Board of Directors In an exciting new development, Fortrea has recently appointed Erin L. Russell to its Board of Directors, signaling a robust commitment to enhancing its strategic direction and governance. This decision comes as part of a collaboration with Starboard Value LP, an investment firm that holds a significant stake in...

Continue Reading
Analyzing the Current Market Sentiment Towards Laureate Education

Updated Category News Views 168

Understanding Laureate Education's Market Position Laureate Education Inc (NYSE: LAUR) has recently shown a decline in its short percent of float, which has dropped 7.46% since the last report. Currently, the company indicates that it has 2.44 million shares sold short. This accounts for about 2.11% of all shares available for trading. Given its current trading volume, it...

Continue Reading